Few people would argue that the rise and fall of hormone levels, whether the hormone in question is estrogen or testosterone, can have a powerful influence on everything from emotions and mood to energy levels and fluctuations in weight. It’s therefore somewhat surprising to learn that scientists do not generally take hormonal differences into consideration when performing animal-based research.
“Biomedical research shows a striking sex bias,” says Emily Jacobs, Ph.D., a Robert Wood Johnson Foundation (RWJF) Health & Society Scholar (2010-2012). “The National Institutes of Health have guidelines about the inclusion of women in human studies, but those rules don’t extend to animal research. In the biological sciences, animal-based studies rely predominantly on male animals and in the fraction of studies that include females, the data are rarely analyzed by sex,” she says.
That’s a very important issue, Jacobs explains, because “human models of brain function and neurological disorders are informed by work conducted at the animal level. But when research is carried out exclusively in male animals and then generalized to females, the conclusions are at best, incomplete and at worst, incorrect. Therefore, it’s unjustified to assume that beyond the reproductive system, sex differences don’t exist. There is an abundance of data to the contrary.”
Jacobs and her collaborator and RWJF mentor, Mark D’Esposito, Ph.D., director of the Henry H. Wheeler Jr., Brain Imaging Center at the University of California, Berkeley, explored the relationship between estrogen and cognition in the study, “Estrogen Shapes Dopamine-Dependent Cognitive Processes: Implications for Women's Health,” published in the April 6, 2011 issue of The Journal of Neuroscience.
A neuroscientist who recently completed her studies at the University of California, Berkeley, Jacobs’ work provides an important example of why studying females yields insights about brain function that would be overlooked in a male-only study. Her research focused on working memory, a cognitive function that underlies problem-solving and reading comprehension. Working memory relies on precise levels of dopamine in the brain’s frontal lobe. Both too little and too much of the neurochemical impairs performance; moderate amounts result in optimal performance. Since estrogen has been shown to enhance dopamine, Jacobs theorized that estrogen levels may affect cognition.
Hormones and the Brain
“For our study, we tracked 24 women over a period of five months, monitoring their menstrual cycles and measuring brain activity when estrogen levels were naturally high and low,” Jacobs says. “We found that estrogen impacts working memory, but the effect is not the same in all women. Moreover, the direction of estrogen’s effect—whether it enhances or impairs performance—was highly dependent on a woman’s baseline level of dopamine.” Women with naturally low dopamine showed a cognitive boost when estrogen levels were elevated, while women with naturally high dopamine performed better when estrogen levels were low.
This line of research has several implications, and one of the most critical relates to the use of dopaminergic drugs (medications that manipulate dopamine levels), such as Ritalin for ADHD and l-DOPA for Parkinson’s disease. “If a boy and a girl present with ADHD and you give them both a drug such as Ritalin, the boy and the girl are going to have very different biological responses to the medication,” Jacobs says.
Another recent study, conducted by Annaliese Beery, Ph.D., a former Robert Wood Johnson Health & Society Scholar (2008-2010), indexed all studies conducted in mammals in 2009, in more than 2,000 articles, 40 journals and across ten disciplines. Eight of the ten disciplines reviewed showed a bias toward relying predominantly on male animals. For this reason, “sex bias in basic science, including pharmacology and neuroscience, may limit progress in public health, since results gleaned from males are being used to draw conclusions about everyone’s health,” Jacobs explains.
“Examining sex differences and, more narrowly, estrogen’s action in the frontal lobe, represents a greatly understudied area of research,” Jacobs says. “While the Women’s Health Initiative, currently the largest study of its kind on women and estrogen, included a measure of global cognition, it was a very general measure and did not have the precision to reveal estrogen’s full impact on brain function.”
Learning More—New Research
“It’s clear that sex differences and hormone effects stretch well beyond the reproductive system. In my upcoming work, I will focus on clarifying the impact estrogen has on brain function with the hope of harnessing that knowledge for improved medical treatment for women,” she says. “For both studies though, I credit my RWJF term with giving me the independence to pursue a unique research trajectory, while simultaneously providing a forum for exploring the implications of my research for society.”
Overall, Jacobs says her goal is “to help change the often unquestioned habit of relying almost exclusively on male animals in basic science, a practice that ultimately ignores the health needs of women.”
The Robert Wood Johnson Foundation Health & Society Scholars program is based on the principle that progress in the field of population health depends upon multidisciplinary collaboration and exchange. Its goal is to improve health by training scholars to investigate the connections among biological, genetic, behavioral, environmental, economic and social determinants of health; and develop, evaluate and disseminate knowledge and interventions that integrate and act on these determinants to improve health. The program is intended to produce leaders who will change the questions asked, the methods employed to analyze problems, and the range of solutions to reduce population health disparities and improve the health of all Americans.
The What's Next Health series features leading thinkers and visionaries. Stanford social scientist & innovator BJ Fogg discusses his model f...
Executive Nurse Fellow Jerry Mansfield explains why the University Hospital and the Richard M. Ross Heart Hospital do not have a BSN-only hi...
Hear from social scientist BJ Fogg, RWJF’s Entrepreneur-in-Residence Thomas Goetz, a team with a vision for creating a social epidemic of sa...
We create new opportunities for better health by investing in health where it starts—in our homes, schools, and jobs.
Team members, grantees, and guests discuss breakthrough ideas that will allow us to move toward solving challenges in health care.
NewPublicHealth spoke with Danny McGoldrick, vice president of research at the Campaign for Tobacco-Free Kids, about “A Broken Promise to Ou...
Imagine a shared national culture of health in which being healthy and staying healthy are esteemed social values.
Patrick M. Krueger recently co-authored a study that examines the characteristics and mortality risks of nondrinker subgroups to explain why...
2013 America’s Health Rankings Finds Significant Progress in National Health - FDA to Phase Out Use of Certain Antimicrobials in Food Animal...
Developing small community homes as alternatives to nursing homes, this radical, new national model for skilled nursing care returns control...
This fall, RWJF held its first ever Pitch Day event with the goal of discovering visionary ideas from a variety of thinkers.
NewPublicHealth spoke with John Auerbach, professor at Northeastern University and the primary author of a report on the Trust, and Cheryl B...